The role of macrilide antibiotics and unwanted effects

Authors

  • Tea Kecka

DOI:

https://doi.org/10.55312/op.vi1.5876

Abstract

Macrolides are a class of drugs used to manage and treat various bacterial infections. Azithromysin, Claritromybin and Erythromycline are commonly used to treat infections like pneumonia, sinusitis, pharyngeitis and almonds. They are also used in uncomplicated skin infections and otitis media in pediatric patients as well as for the treatment of sexually transmitted infections like gonococcal and chlamydialyte infections. The purpose of the study is to provide information about the recognition and side effects of macrillide antibiotics.

Keywords:

macrilide, infections, effects, administration

Downloads

Download data is not yet available.

References

  1. NCT02960503. Macrolide therapy to improve forced expiratory volume in 1 second in adults with sickle cell disease [Macrolide therapy to improve forced expiratory volume in 1 second in adults with sickle cell disease: a feasibility trial]. clinicaltrials.gov/ct2/show/record/

  2. NCT02960503 (first received 2 November 2016).

  3. Agarwal E, Bajaj P, Naik SB, Pradeep AR. Locally delivered 0.5% azithromycin as an adjunct to non‐surgical treatment in patients with chronic periodontitis with type 2 diabetes: a randomized controlled clinical trial. Journal of Periodontology 2017;88(12):1281‐7.

  4. https://www.drugs.com/drug-class/macrolides.html

  5. https://www.ncbi.nlm.nih.gov/books/NBK548398/

  6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353052/

  7. Kostadima E, Tsiodras S, Alexopoulos EI, Kaditis AG, Mavrou I, Georgatou N, et al. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. European Respiratory Journal 2004; Vol. 23, issue 5:714‐7

  8. https://www.rxlist.com/how_do_macrolides_work/drug-class.htm

Downloads

Published

2024-11-24

How to Cite

Kecka, T. (2024). The role of macrilide antibiotics and unwanted effects. Optime, (1), 159–162. https://doi.org/10.55312/op.vi1.5876

Issue

Section

Articles